Biomatics Capital
Status
INACTIVE
Global HQ
Seattle, Washington, United States
Countries of investment
- USA and
Investment stages
- Seed
- Series A
- Series B
- Series C
- -
Industries
- Health Tech
- Biotechnology
About
Biomatics Capital is a venture capital firm dedicated to transforming health care and medicine through strategic investments. The firm is at a tipping point where the convergence of genomics and digital data is enabling revolutionary advancements in therapeutics, diagnostics, and delivery models. Biomatics Capital has a savvy and nimble team with exceptional vision and execution capabilities ranging from gene editing to DNA synthesis. Their passion for groundbreaking technologies combined with their business acumen provides entrepreneurs with unparalleled support and a vital network of experts, driving the next generation of companies toward exceptional value and innovation.
Biomatics Capital is a venture capital firm dedicated to transforming health care and medicine through strategic investments. The firm is at a tipping point where the convergence of genomics and digital data is enabling revolutionary advancements in therapeutics, diagnostics, and delivery models. Biomatics Capital has a savvy and nimble team with exceptional vision and execution capabilities ranging from gene editing to DNA synthesis. Their passion for groundbreaking technologies combined with their business acumen provides entrepreneurs with unparalleled support and a vital network of experts, driving the next generation of companies toward exceptional value and innovation.
Investment Thesis
Biomatics Capital focuses on transforming health care and medicine through investments in breakthrough science, particularly at the convergence of genomics and digital data, which enables the development of superior therapeutics, diagnostics, and delivery models.
Team
Boris Nikolic
M.D. – Managing Director
Julie Sunderland – Cofounder
Errik Anderson – Venture Partner
Mike Poole
M.D. – Venture Partner
Yeon Cramer – Business Operations Manager
Portfolio
Denali Therapeutics
BlackThorn Therapeutics
Grail
Encodia
Omniome
Cytrellis
Verve